Prognostic value of adjuvant therapy in T4 non-small cell lung cancer: An inverse probability of treatment weighting analysis.

Ya-Ting SongSheng-Li YangZhen FuXue-Han LiuSi-Yu YanZhi-Hui WangTing-Ting QinHong-Wei JiangYang JinPing Yin

Published in: Thoracic cancer (2019)

In this population-based cohort, ACT prolonged the survival of patients aged 21-65 with a tumor > 7 cm, with or without PORT. Inverse probability of treatment weighting can estimate the treatment effect and is suitable for use with survival data.

Keyphrases

ejection fraction
combination therapy
electronic health record
prognostic factors
free survival